• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100P在胰腺癌细胞侵袭中的作用是通过细胞骨架变化和组织蛋白酶D的调节介导的。

The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.

作者信息

Whiteman Hannah J, Weeks Mark E, Dowen Sally E, Barry Sayka, Timms John F, Lemoine Nicholas R, Crnogorac-Jurcevic Tatjana

机构信息

Centre for Molecular Oncology, Institute of Cancer, Barts, UK.

出版信息

Cancer Res. 2007 Sep 15;67(18):8633-42. doi: 10.1158/0008-5472.CAN-07-0545.

DOI:10.1158/0008-5472.CAN-07-0545
PMID:17875703
Abstract

Up-regulation of S100P, a member of the S100 calcium-binding protein family, is an early molecular event in the development of pancreatic cancer and it is expressed at high levels in both precursor lesions and invasive cancer. To gain more insight into the molecular mechanisms underlying the functional roles of this protein, we stably overexpressed S100P in the Panc1 pancreatic cancer cell line and identified the consequent changes in global protein expression by two-dimensional difference in-gel electrophoresis. The observed changes in target proteins were confirmed by Western blot analysis and immunofluorescence, whereas their functional effect was investigated using motility and invasion assays. In this study, we have shown that overexpression of S100P led to changes in the expression levels of several cytoskeletal proteins, including cytokeratins 8, 18, and 19. We have also shown disorganization of the actin cytoskeleton network and changes in the phosphorylation status of the actin regulatory protein cofilin. Additionally, we have shown that overexpression of S100P leads to increased expression of another early pancreatic cancer marker, S100A6, as well as the aspartic protease cathepsin D, both of which are involved in cellular invasion. Functional studies showed that the increased invasive potential of S100P-overexpressing cells was at least partially due to the increase in cathepsin D expression. In summary, our data suggest that these changes could contribute to the metastatic spread of pancreatic cancer and may explain the devastating prognosis of this disease.

摘要

S100钙结合蛋白家族成员S100P的上调是胰腺癌发生过程中的早期分子事件,它在前体病变和浸润性癌中均高表达。为了更深入了解该蛋白功能作用的分子机制,我们在Panc1胰腺癌细胞系中稳定过表达S100P,并通过二维差异凝胶电泳鉴定由此引起的整体蛋白质表达变化。通过蛋白质印迹分析和免疫荧光证实了靶蛋白的观察变化,而使用迁移和侵袭试验研究了它们的功能作用。在本研究中,我们表明S100P的过表达导致几种细胞骨架蛋白表达水平的变化,包括细胞角蛋白8、18和19。我们还表明肌动蛋白细胞骨架网络紊乱以及肌动蛋白调节蛋白丝切蛋白的磷酸化状态发生变化。此外,我们表明S100P的过表达导致另一种早期胰腺癌标志物S100A6以及天冬氨酸蛋白酶组织蛋白酶D的表达增加,这两者都参与细胞侵袭。功能研究表明,S100P过表达细胞侵袭潜能的增加至少部分归因于组织蛋白酶D表达的增加。总之,我们的数据表明这些变化可能有助于胰腺癌的转移扩散,并可能解释这种疾病的不良预后。

相似文献

1
The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.S100P在胰腺癌细胞侵袭中的作用是通过细胞骨架变化和组织蛋白酶D的调节介导的。
Cancer Res. 2007 Sep 15;67(18):8633-42. doi: 10.1158/0008-5472.CAN-07-0545.
2
S100P promotes pancreatic cancer growth, survival, and invasion.S100P促进胰腺癌的生长、存活及侵袭。
Clin Cancer Res. 2005 Aug 1;11(15):5356-64. doi: 10.1158/1078-0432.CCR-05-0092.
3
High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.高核S100A6(钙周期蛋白)与胰腺癌患者的不良生存显著相关。
Cancer Res. 2005 Apr 15;65(8):3218-25. doi: 10.1158/0008-5472.CAN-04-4311.
4
S100P is an early developmental marker of pancreatic carcinogenesis.S100P是胰腺癌发生的早期发育标志物。
Clin Cancer Res. 2006 Sep 15;12(18):5411-6. doi: 10.1158/1078-0432.CCR-06-0298.
5
Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.骨唾液蛋白对胰腺癌细胞生长、侵袭和转移的影响。
Cancer Lett. 2007 Jan 8;245(1-2):171-83. doi: 10.1016/j.canlet.2006.01.002. Epub 2006 Feb 20.
6
The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.S100A6在胰腺癌发展中的作用及其作为诊断标志物和治疗靶点的临床意义。
Clin Cancer Res. 2005 Nov 1;11(21):7785-93. doi: 10.1158/1078-0432.CCR-05-0714.
7
Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.胰腺癌中的分子改变:表达谱分析显示S100基因的表达失调非常普遍。
J Pathol. 2003 Sep;201(1):63-74. doi: 10.1002/path.1418.
8
Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.S100A2在胰腺癌中的过表达与疾病进展及不良预后相关。
J Pathol. 2007 Nov;213(3):275-82. doi: 10.1002/path.2250.
9
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.利用定量聚合酶链反应评估前列腺干细胞抗原作为胰腺癌的肿瘤标志物。
Ann Surg Oncol. 2006 Dec;13(12):1645-54. doi: 10.1245/s10434-006-9029-5.
10
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.假定的转移抑制基因Cap43/NDRG1/Drg-1通过调节血管生成抑制胰腺癌肿瘤生长
Cancer Res. 2006 Jun 15;66(12):6233-42. doi: 10.1158/0008-5472.CAN-06-0183.

引用本文的文献

1
The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma.施万细胞在胰腺导管腺癌神经周浸润中的支持作用。
Front Pharmacol. 2025 Jun 11;16:1540027. doi: 10.3389/fphar.2025.1540027. eCollection 2025.
2
MuCST: restoring and integrating heterogeneous morphology images and spatial transcriptomics data with contrastive learning.MuCST:通过对比学习恢复和整合异质形态图像与空间转录组学数据。
Genome Med. 2025 Mar 13;17(1):21. doi: 10.1186/s13073-025-01449-1.
3
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.
GNAS 变异在实体瘤中的分子和临床病理影响。
J Clin Oncol. 2024 Nov 10;42(32):3847-3857. doi: 10.1200/JCO.24.00186. Epub 2024 Aug 9.
4
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer.S100PBP 受突变 KRAS 调控,在胰腺癌中发挥肿瘤抑制作用。
Oncogene. 2023 Nov;42(46):3422-3434. doi: 10.1038/s41388-023-02851-y. Epub 2023 Oct 4.
5
Recent Advances of Proteomics in Management of Acute Kidney Injury.蛋白质组学在急性肾损伤管理中的最新进展
Diagnostics (Basel). 2023 Aug 11;13(16):2648. doi: 10.3390/diagnostics13162648.
6
LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p.LHPP 抑制 PDAC 细胞的活力、迁移和增殖,并显著影响 SDC1 和 S100p 的表达。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231177807. doi: 10.1177/15330338231177807.
7
Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.鉴定基因组生物标志物及其通路串扰,以揭示胶质母细胞瘤中的机制联系。
IET Syst Biol. 2023 Aug;17(4):143-161. doi: 10.1049/syb2.12066. Epub 2023 Jun 5.
8
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives.胰腺癌中的S100蛋白:当前认知与未来展望
Front Oncol. 2021 Aug 30;11:711180. doi: 10.3389/fonc.2021.711180. eCollection 2021.
9
Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer.钙结合蛋白S100P促进肿瘤进展,但增强乳腺癌的化疗敏感性。
Front Oncol. 2020 Sep 15;10:566302. doi: 10.3389/fonc.2020.566302. eCollection 2020.
10
Schwann Cell Stimulation of Pancreatic Cancer Cells: A Proteomic Analysis.雪旺细胞对胰腺癌细胞的刺激作用:蛋白质组学分析
Front Oncol. 2020 Aug 25;10:1601. doi: 10.3389/fonc.2020.01601. eCollection 2020.